Therapeutic Glaucoma

Study focuses on technology to unveil optical texture and trajectories of the axonal fiber bundles on retina

A research team led by the Department of Ophthalmology, School of Clinical Medicine, LKS Faculty of Medicine of The University of Hong Kong, with collaborators from the Faculty of Medicine of The Chinese University of Hong Kong and local and international partners, have developed a new technology ROTA to unveil the optical texture and trajectories of the axonal fiber bundles on the retina.

Study: Age at time of Type 2 diabetes or hypertension diagnosis linked to glaucoma

Timing of type 2 diabetes or hypertension diagnosis may impact the risk of primary open-angle glaucoma.

Alternative delivery of glaucoma medications more than a dream

Nicox’s NCX 470 Dolomites Phase 2 results published in Journal of Glaucoma

April 11, 2022

NCX 470 is currently enrolling patients in two multi-regional Phase 3 glaucoma clinical trials, Mont Blanc and Denali. The objective of these two trials is to demonstrate statistically superior IOP lowering of once daily dosed NCX 470